mTORC2 acts as a gatekeeper for mTORC1 deficiency-mediated impairments in ILC3 development.
Deng YF, Wu ST, Peng HY, Tian L, Li YN, Yang Y, Meng M, Huang LL, Xiong PW, Li SY, Yang QL, Wang LL, Li XY, Li LP, Lu XL, Li XH, Wei YL, Xiao ZH, Yu JH, Deng YC.
Deng YF, et al. Among authors: deng yc.
Acta Pharmacol Sin. 2023 Nov;44(11):2243-2252. doi: 10.1038/s41401-023-01120-8. Epub 2023 Jul 5.
Acta Pharmacol Sin. 2023.
PMID: 37407703